{"id":15735,"date":"2023-04-03T02:56:29","date_gmt":"2023-04-03T02:56:29","guid":{"rendered":"https:\/\/www.newprojectstracker.com\/blog\/?p=15735"},"modified":"2023-04-04T03:00:12","modified_gmt":"2023-04-04T03:00:12","slug":"tube-investments-of-india-forays-into-pharma-sector","status":"publish","type":"post","link":"https:\/\/www.newprojectstracker.com\/blog\/tube-investments-of-india-forays-into-pharma-sector\/","title":{"rendered":"Tube Investments of India forays into pharma sector"},"content":{"rendered":"\n\n\n\t<div class=\"dkpdf-button-container\" style=\" text-align:right \">\n\n\t\t<a class=\"dkpdf-button\" href=\"\/blog\/wp-json\/wp\/v2\/posts\/15735?pdf=15735\" target=\"_blank\"><span class=\"dkpdf-button-icon\"><i class=\"fa fa-file-pdf-o\"><\/i><\/span> Download PDF Report<\/a>\n\n\t<\/div>\n\n\n\n\n\n<p><img src=\"https:\/\/www.newprojectstracker.com\/blog\/wp-content\/uploads\/2023\/04\/Tube-Investments-of-India-forays-into-pharma-sector.jpg\" \/><\/p>\n<p>The 54,722-crore Murugappa Group, which includes Tube Investments of India (TII), announced its entry into the pharmaceutical industry. It will work on developing active medicinal compounds through contract manufacturing (API).<\/p>\n<p>Active pharmaceutical ingredients (API) and contract development and manufacturing organisations (CDMO) have been selected by TII as its new business lines.<\/p>\n<p>TII will incorporate a new subsidiary for the establishment of CDMO business and it will focus on API and other products.<\/p>\n<p>The company proposes to invest up to `285 crore into this subsidiary in the form of equity and compulsorily convertible preference shares in tranches.<\/p>\n<p>N Govindarajan, former MD of Aurobindo Pharma and a well-recognised industry professional, has been roped in to form the subsidiary.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Download PDF Report The 54,722-crore Murugappa Group, which includes Tube Investments of India (TII), announced its entry into the pharmaceutical industry. It will work on developing active medicinal compounds through contract manufacturing (API)&#8230;. <\/p>\n","protected":false},"author":1,"featured_media":15736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"spay_email":""},"categories":[163],"tags":[1615],"jetpack_featured_media_url":"https:\/\/www.newprojectstracker.com\/blog\/wp-content\/uploads\/2023\/04\/Tube-Investments-of-India-forays-into-pharma-sector.jpg","acf":[],"_links":{"self":[{"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/posts\/15735"}],"collection":[{"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/comments?post=15735"}],"version-history":[{"count":1,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/posts\/15735\/revisions"}],"predecessor-version":[{"id":15737,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/posts\/15735\/revisions\/15737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/media\/15736"}],"wp:attachment":[{"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/media?parent=15735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/categories?post=15735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newprojectstracker.com\/blog\/wp-json\/wp\/v2\/tags?post=15735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}